Results 31 to 40 of about 10,168,516 (390)

Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort

open access: yesImmunity, Inflammation and Disease, 2023
Introduction Vaccination plays a fundamental role in mastering the COVID‐19 pandemic and protecting vulnerable groups. Persons with autoimmune inflammatory rheumatic diseases (AIIRD) requiring immunosuppressive therapies are prioritized for vaccination ...
Batool Zamani   +5 more
doaj   +1 more source

NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases

open access: yesFrontiers in Immunology, 2021
Autoimmune diseases are a broad spectrum of human diseases that are characterized by the breakdown of immune tolerance and the production of autoantibodies.
Yiwen Zhang   +3 more
semanticscholar   +1 more source

Autoimmune diseases [PDF]

open access: yes, 2009
Autoimunosne bolesti su vrlo heterogena skupina bolesti, koje imaju zajedničku karakteristiku, a to je proizvodnja autoreaktivnih T-stanica ili autoreaktivnih antitijela.
Perić, Maja
core   +3 more sources

Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases

open access: yesClinical Case Reports, 2023
Key Clinical Message The immunosuppressant agents should be considered earlier in the course of treatment with rituximab, possibly after the unfavorable response at first cycle of treatment, especially in male patients and those with high BMI.
Zeinab Aryanian   +6 more
doaj   +1 more source

COVID-19 and autoimmune diseases

open access: yesCurrent Opinion in Rheumatology, 2020
Purpose of review The aim of this study was to evaluate the relationship between infection with SARS-CoV-2 and autoimmunity. Recent findings Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome (SARS ...
Yu Liu, A. Sawalha, Q. Lu
semanticscholar   +1 more source

Tolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation [PDF]

open access: yes, 2014
Autoimmune diseases are driven by immune cells that recognize self-tissues. A major goal for treatment strategies for autoimmune diseases is to turn off or tolerize self-reactive immune cells such as CD4 T cells that coordinate tissue damage in many ...
A. David   +38 more
core   +1 more source

Clinical Characteristics and Treatment Outcomes of Scleromyxedema: A 10-Year Retrospective Survey

open access: yesCase Reports in Dermatology, 2022
Scleromyxedema is a rare but important mucinosis disorder of the skin that is presented with dermatological manifestations such as waxy papules, diffuse induration, and nondermatologic involvements like neurological and renal disorders.
Abtin Ansari   +6 more
doaj   +1 more source

Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria

open access: yesAllergy Asthma and Immunology Research, 2021
Purpose Patients with chronic spontaneous urticaria (CSU) have an increased risk for comorbid autoimmune diseases. In this retrospective multicenter study of CSU patients, we evaluated clinical and laboratory features of CSU associated with a higher risk
P. Kolkhir   +17 more
semanticscholar   +1 more source

Emerging patterns of genetic overlap across autoimmune disorders. [PDF]

open access: yes, 2012
Most of the recently identified autoimmunity loci are shared among multiple autoimmune diseases. The pattern of genetic association with autoimmune phenotypes varies, suggesting that certain subgroups of autoimmune diseases are likely to share ...
Criswell, Lindsey A   +1 more
core   +1 more source

Two asymptomatic facial erythematous macules in an adult male

open access: yesSkin Health and Disease, 2023
Pemphigus is a group of autoimmune bullous disorders with different types. Pemphigus foliaceous (PF) is a difficult‐to‐diagnosis disorder which shares clinical features with many dermatoses.
Kamran Balighi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy